Skip to main content

TUDOR INVESTMENT CORP ET AL

Position in ABVX — Abivax S.A.

CIK 923093 STAMFORD, CT

Position in ABVX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$24,964,262
+$13,649,878 QoQ
Shares Held
187,335
+84.4% QoQ
Ownership
0.215%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#57
of 302 holders
Holding Since
Dec 2023
5 quarters on record
Voting authority Sole 50% Shared 50% None 0%

Common Shares in ABVX Over Time

Shares Held

Position Value (USD)

Derivatives in ABVX

reported options exposure · as of Jun 30, 2026
CallValue
$21,041,754
CallShares
157,900
PutValue
$23,946,822
PutShares
179,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TUDOR INVESTMENT CORP ET AL holds $411,209,149 across 107 Biotechnology names. ABVX ranks #4 (6.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 ABVX
Abivax S.A.
This page
187,335 $24,964,262

All Filings in ABVX

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $24,964,262 187,335
2026-06-30 $23,946,822 179,700
2026-06-30 $21,041,754 157,900
2026-03-31 $1,636,845 14,700
2026-03-31 $11,314,384 101,611
2025-12-31 $7,309,141 54,200
2025-12-31 $6,715,779 49,800
2025-12-31 $3,848,222 28,536
2025-09-30 $2,791,766 32,883
2023-12-31 $262,150 24,500